Gabriela Kot | Rheumatology | Young Scientist Award

Published on by Top Pharmaceutical

Young Scientist Award

Gabriela Kot
Affiliation Poznan University of Medical Sciences
Country Poland
Scopus ID 59492769200
Documents 7
Citations 9
h-index 2
Subject Area Rheumatology
Event International Top Pharmaceutical Awards
ORCID 0009-0004-3205-6225

Gabriela Kot – Poznan University of Medical Sciences

Gabriela Kot is a researcher affiliated with Poznan University of Medical Sciences in Poland, with scholarly activity documented across rheumatology, clinical medicine, gastrointestinal research, and related biomedical fields. Her ORCID record identifies seven works and provides evidence of continued engagement with peer-reviewed research. [1] Her publication portfolio includes studies addressing rheumatoid arthritis, monoclonal antibody therapy, thrombotic microangiopathy, digestive-system biology, and clinical outcomes. [2]

Abstract

Gabriela Kot’s documented research activity represents a multidisciplinary biomedical profile with particular relevance to rheumatology and clinical research. Her record includes seven works, while the supplied bibliometric information reports nine citations and an h-index of 2. The publication record includes observational research, therapeutic comparisons, case-based clinical investigation, and studies of disease mechanisms. Her work on rheumatoid arthritis and monoclonal antibodies is especially aligned with pharmaceutical and therapeutic research, providing a relevant basis for consideration within a Young Scientist Award framework. [3]

Keywords

Gabriela Kot; Young Scientist Award; Rheumatology; Rheumatoid Arthritis; Monoclonal Antibodies; Clinical Research; Therapeutics; Thrombotic Microangiopathy; Biomedical Research; Pharmaceutical Research.

Introduction

The research record of Gabriela Kot demonstrates participation in contemporary biomedical investigations spanning rheumatology, clinical medicine, gastroenterology, nephrology, and therapeutic science. The available ORCID information confirms employment at the Poznan University of Medical Sciences and lists seven research works. [1] This breadth indicates an interdisciplinary approach in which clinical observations and disease-focused studies contribute to the broader evidence base.

Research Profile

The supplied profile identifies Rheumatology as the principal subject area and reports seven documents, nine citations, and an h-index of 2. Her publications include research concerning rheumatoid arthritis, particularly antinuclear antibodies and monoclonal antibody treatment, alongside investigations in other clinical domains. The profile therefore reflects developing research experience supported by a varied publication portfolio.[4]

Research Contributions

Among the documented contributions is a cross-sectional observational study examining antinuclear antibodies in rheumatoid arthritis, providing clinical evidence relevant to disease characterization. [4] Another publication compares the efficacy and safety of monoclonal antibodies in rheumatoid arthritis, directly connecting her research activity with therapeutic evaluation. [5] Additional works address rare clinical complications, gastrointestinal biology, surveillance, and quality-of-life outcomes.

Publications

The publication record contains seven works listed in the supplied ORCID document, including journal articles published in 2024, 2025, and 2026. [1] The works include studies in Antibodies, Cancers, Medicina, Biochemical and Biophysical Research Communications, and the American Journal of Case Reports. Several records provide DOI identifiers, enabling direct verification through publisher or DOI services.[4]

Research Impact

The supplied bibliometric profile records nine citations and an h-index of 2, indicating measurable scholarly uptake of the documented publications. [3] The research themes also have practical relevance because they encompass therapeutic safety, disease assessment, clinical surveillance, and patient outcomes. Continued publication in peer-reviewed journals and further development of focused rheumatology research may strengthen the long-term visibility and impact of this emerging research profile.[4]

Award Suitability

Gabriela Kot’s documented publication activity and identified subject area provide a reasonable scholarly basis for consideration for the Young Scientist Award. Her work directly includes rheumatoid arthritis and monoclonal antibody research, subjects relevant to pharmaceutical and therapeutic sciences. [4] The multidisciplinary nature of her other publications further demonstrates engagement with clinically relevant biomedical questions, although award decisions should remain subject to the formal evaluation criteria of the International Top Pharmaceutical Awards. [1]

Conclusion

Gabriela Kot has an emerging research profile centered on rheumatology and supported by publications across several biomedical disciplines. The available record documents seven works, nine citations, and an h-index of 2, together with research addressing rheumatoid arthritis, therapeutic antibodies, clinical complications, and related medical questions.These activities establish a relevant foundation for continued scientific development and consideration within an early-career research recognition framework. [1]

References

  1. Elsevier. (n.d.). Scopus author details: Gabriela Kot, Author ID 59492769200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59492769200
  2. Kot, G., et al. (2026). Diagnostic Challenges in Atypical Hemolytic Uremic Syndrome: A Case of Artificial Mitral Valve Dysfunction as a Possible Trigger for Severe Thrombotic Microangiopathy. American Journal of Case Reports. DOI: 10.12659/AJCR.948516.
    https://doi.org/10.12659/AJCR.948516
  3. Cholerzyńska, H., Kot, G., Świątek, Ł., & Grygiel-Górniak, B. (2026). Beyond the Surface: Antinuclear Antibodies in Rheumatoid Arthritis—Experiences from a Single-Center, Cross-Sectional Observational Study. Antibodies, 15(4), 58. DOI: 10.3390/antib15040058.
    https://doi.org/10.3390/antib15040058
  4. Kot, G., Świątek, Ł., Sikorska, D., & Samborski, W. (2025). Comparative efficacy and safety of monoclonal antibodies in rheumatoid arthritis. Wydawnictwo Akademia Medycyny. DOI: 10.53139/FW.20251806.
    https://doi.org/10.53139/FW.20251806
  5. ORCID. (2026). Gabriela Kot, ORCID record and works. ORCID.
    https://orcid.org/0009-0004-3205-6225

Emran Ali | Regulatory Affairs | Excellence in Research Award | 2738

Published on by Top Pharmaceutical

Excellence in Research Award

Emran Ali – Alcorn State University, United States

Emran Ali
Affiliation Alcorn State University
Country United States
Scopus ID 56979730600
Documents 40
Citations 422
h-index 13
Subject Area Regulatory Affairs
Event International Top Pharmaceutical Awards
ORCID 0000-0002-1957-4392

Emran Ali is a researcher and faculty member at Alcorn State University whose documented work focuses on plant health, molecular diagnostics, plant pathology, biotechnology, and disease management. His research includes field-oriented diagnostic approaches and technologies designed to improve the detection and management of crop diseases. [1]

Abstract

Emran Ali’s research profile reflects an interdisciplinary approach to plant disease diagnosis, molecular detection, and agricultural biosecurity. His published work addresses rapid diagnostic methods, including loop-mediated isothermal amplification and other field-deployable approaches. These activities connect laboratory research with practical disease-management needs and technology transfer. [2]

Keywords

Plant pathology, molecular diagnostics, biotechnology, LAMP, crop disease detection, agricultural biosecurity, Phytophthora, plant disease management, horticulture, disease surveillance.

Introduction

Ali is affiliated with Alcorn State University, where his current academic work includes horticulture and applied plant-health research. University and professional sources identify his activities in advanced disease diagnosis, crop protection, extension, and research collaborations. His research is particularly relevant to rapid pathogen detection and practical agricultural diagnostics.[3]

Research Profile

The research profile encompasses plant molecular biology, biotechnology, plant pathology, advanced disease diagnosis, and host–microbe interactions. His work has included development and application of diagnostic assays intended to shorten the time between pathogen detection and management decisions.  This combination of molecular methods and field application provides a foundation for research with practical agricultural relevance.[4]

Research Contributions

Ali has contributed to research on rapid detection of plant pathogens, including Phytophthora capsici and other disease-causing organisms. His publications demonstrate experience with LAMP-based detection and disease surveillance. [5] More recent work at Alcorn State University has extended this research toward field-deployable diagnostics and crop biosecurity.

Publications

Selected publications demonstrate a continuing interest in plant disease diagnostics and pathogen management. These works include collaborative research on Phytophthora detection, turfgrass disease diagnosis, rapid nematode detection, and recent molecular surveillance of cucurbit downy mildew. The publication record therefore provides evidence of methodological and applied research activity.[4]

Research Impact

The practical orientation of this research is reflected in projects supporting rapid crop disease diagnosis and agricultural biosecurity. Alcorn State University has reported Ali’s involvement in USDA-supported work applying portable diagnostic technologies for underserved family farms. Such activities connect research outputs with extension, training, and technology adoption.[4]

Award Suitability

The Excellence in Research Award provides a recognition framework for documented scholarly contributions, research productivity, and practical scientific relevance. Ali’s publication record, collaborative research, molecular diagnostic expertise, and applied disease-management activities provide a substantive basis for consideration. The profile may be particularly relevant to interdisciplinary pharmaceutical and biotechnology audiences interested in diagnostics, biosecurity, and translational research.[4]

Conclusion

Emran Ali’s research profile combines plant pathology, molecular diagnostics, biotechnology, and applied disease management. His documented publications and research projects demonstrate sustained engagement with pathogen detection and field-level diagnostic applications. These contributions provide a scholarly basis for recognition through the Excellence in Research Award within an interdisciplinary research environment.

References

  1. Hudson, O., Waliullah, S., Hand, J., Gazis-Seregina, R., Baysal-Gurel, F., & Ali, M. E. (2020). Detection of Phytophthora capsici in irrigation water using loop-mediated isothermal amplification. Journal of Visualized Experiments, 160. DOI: https://doi.org/10.3791/61478
  2. Stackhouse, T., Martinez-Espinoza, A. D., & Ali, M. E. (2020). Turfgrass disease diagnosis: Past, present, and future. Plants, 9(11), 1544. DOI: https://doi.org/10.3390/plants9111544
  3. Waliullah, S., Bell, J., Jagdale, G., Stackhouse, T., Hajihassani, A., Brenneman, T., & Ali, M. E. (2020). Rapid detection of pecan root-knot nematode, Meloidogyne partityla, in laboratory and field conditions using loop-mediated isothermal amplification. Scientific Reports, 10. DOI: https://pubmed.ncbi.nlm.nih.gov/32555580/
  4. Hudson, O., Waliullah, S., Ji, P., Hand, J., Price, J., Hancock, G., Carlson, S., Kichler, J., Price, T., Dowdy, M., Hayes, B., & Ali, E. (2021). Detection of Phytophthora capsici from irrigation ponds in South Georgia. Plant Health Progress, 22(3). DOI: https://doi.org/10.1094/PHP-02-21-0043-FI
  5. Ghimire, B., Avin, F. A., Waliullah, S., Ali, E., & Baysal-Gurel, F. (2023). Real-time and rapid detection of Phytopythium vexans using loop-mediated isothermal amplification assay. Plant Disease, 107(11). DOI: https://doi.org/10.1094/PDIS-08-22-1944-RE

Gabriella Iheanacho | Supplement validation | Innovative Research Award

Published on by Top Pharmaceutical

Innovative Research Award

Gabriella Iheanacho
Affiliation Clemson University
Country United States
Google Scholar FxVR15oAAAAJ&hl
Documents 7
Citations 42
h-index 3
Subject Area Supplement Validation
Event International Top Pharmaceutical Awards

Gabriella Iheanacho – Clemson University

Gabriella Iheanacho is a graduate research assistant at Clemson University whose documented research profile encompasses animal and veterinary science, with particular emphasis on ruminant nutrition and meat science. Her scholarly record includes studies involving poultry nutrition, livestock characterization, skeletal muscle biology, and dietary supplementation, providing an interdisciplinary foundation for research recognition. [1]

Abstract

Gabriella Iheanacho’s research portfolio reflects work across animal nutrition, poultry production, livestock characterization, and skeletal muscle development. Her publications investigate dietary supplementation, physiological responses, morphometric characterization, and cellular mechanisms associated with muscle growth. These areas demonstrate an evidence-based approach to applied biological research and provide a suitable scholarly context for consideration under the Innovative Research Award.[2]

Keywords

Gabriella Iheanacho; ruminant nutrition; meat science; animal nutrition; poultry science; broiler chickens; dietary supplementation; skeletal muscle; satellite cells; livestock research; garlic and ginger; ovine muscle growth; animal physiology; nutritional science; applied research.

Introduction

Research in animal and veterinary sciences increasingly integrates nutrition, physiology, genetics, and cellular biology to address productivity and biological development. Iheanacho’s documented work fits within this multidisciplinary environment. Her studies include broiler growth and blood parameters, goat morpho-biometric characterization, and experimental investigation of nutritional influences on ovine muscle biology. [2]

Research Profile

The research profile is centered on animal nutrition and meat science, while the publication record shows collaboration across academic and research institutions. Her work ranges from applied feeding experiments to laboratory and molecular investigations. This breadth is particularly evident in recent research examining amino acid derivatives, polyphenols, satellite-cell activity, transcriptomic responses, and muscle growth in sheep.

Research Contributions

Her collaborative research also extends to livestock characterization and muscle biology. Work on West African Dwarf goats applied multivariate analytical methods to morpho-biometric traits, while subsequent ovine research investigated nutritional supplementation, satellite-cell proliferation and differentiation, muscle growth, and associated molecular responses. [2] [5]

Publications

The documented publication record includes seven works. Among the identifiable publications are research on broiler carcass and organ relationships, West African Dwarf goat characterization, garlic and ginger supplementation, ovine muscle development, and satellite-cell responses during late gestation. These publications collectively illustrate progression from applied animal production research toward more specialized investigations of nutrition and muscle biology.[2]

Research Impact

The supplied Google Scholar profile records 42 citations and an h-index of 3, indicating measurable scholarly use of the research output. The profile also records an i10-index of 2. One listed 2022 article has 20 citations, while the 2023 goat characterization paper has 14 citations, representing substantial visibility within the available publication record. [1]

Award Suitability

The Innovative Research Award is relevant to a profile demonstrating original investigation across complementary research areas. Iheanacho’s record includes applied nutrition studies alongside investigations of cellular and molecular mechanisms underlying muscle development. The combination of experimental approaches, collaborative publications, and measurable citation activity provides a reasonable academic basis for consideration for recognition through the International Top Pharmaceutical Awards.[5]

Conclusion

Gabriella Iheanacho’s documented scholarly work presents a developing research profile focused on animal nutrition, meat science, poultry production, livestock biology, and skeletal muscle research. Her publication activity, citation record, and multidisciplinary collaborations provide evidence of sustained academic engagement. The available record therefore supports consideration of her research portfolio for the Innovative Research Award.

References

  1. Google Scholar. (2026). Gabriella Iheanacho: Google Scholar profile. Google Scholar.
    https://scholar.google.com/citations?user=FxVR15oAAAAJ&hl=en&authuser=1
  2. Okoro, V. M. O., Chikereuba, U., Iheanacho, G., Ogundu, A., Chukwuocha, C., Chikaodinaka, F., Ifediba, C., Kadurumba, O. E., Ogundu, U., & Iloeje, M. (2023). West African Dwarf goat populations of tropical rainforest zone: Application of multivariate analysis tools on their characterization using morpho-biometric traits. Tropical Animal Health and Production, 55(3), 222.
    https://doi.org/10.1007/s11250-023-03641-0
  3. Iheanacho, G. C., Ajayi, E. A., Sholademi, E. L., Abu, O. A., Akindoyin, M. O., Abolude, A. T., Judo, O., Dahunsi, P. O., & Odoemene, E. C. (2024). Haematology and serum biochemistry of broiler chickens on dietary supplementation of garlic and ginger powder. American Journal of Agricultural Science, Engineering, and Technology, 8(3), 1–9.
    https://doi.org/10.54536/ajaset.v8i3.3335
  4. Ajayi, E. A., Sholademi, E. L., Abu, O. A., Iheanacho, G. C., Odoemene, E. C., Abolude, A. T., Judo, O., Akindoyin, M. O., & Dahunsi, P. O. (2024). Growth performance of broiler chickens on dietary supplementation of garlic and ginger powder. American Journal of Agricultural Science, Engineering, and Technology, 8(3), 10–17.
    https://doi.org/10.54536/ajaset.v8i3.3491
  5. Iheanacho, G. C., Udoka, A. N. S., Klotz, J. L., & Duckett, S. K. (2026). Effect of amino acid derivatives and polyphenol supplementation on ovine muscle growth in vitro and in vivo. Muscles, 5(3), 52.
    https://doi.org/10.3390/muscles5030052

Cesar Poli | Biopharmaceutics | Innovative Research Award

Published on by Top Pharmaceutical

Innovative Research Award

Cesar Poli – Federal University of Rio Grande do Sul, Brazil

Cesar Poli
Affiliation Federal University of Rio Grande do Sul
Country Brazil
Scopus ID 13408393000
Documents 56
Citations 719
h-index 16
Subject Area Biopharmaceutics
Event International Top Pharmaceutical Awards
ORCID 0000-0002-8469-0779

Cesar Poli is a researcher and Associate Professor at the Federal University of Rio Grande do Sul (UFRGS), Brazil. His documented academic profile includes training in Agronomy, Animal Science and Pastoral Science, together with research activity involving sheep production, pasture management, production systems and ruminant nutrition. His ORCID record also identifies continuing academic employment at UFRGS and international research collaborations. [1]

Abstract

The Innovative Research Award profile recognizes the documented scholarly activities of Cesar Poli and presents his research record in an academic context. Available profile information records his association with UFRGS, postgraduate education, international collaborations, publication activity and peer-review participation. His research portfolio includes pasture-based production, sheep management, ruminant nutrition, animal behaviour and plant bioactive compounds. [1]

Keywords

Keywords: Cesar Poli, Innovative Research Award, Biopharmaceutics, Animal Science, Ruminant Nutrition, Pasture Management, Sheep Production, Grazing Systems, Plant Bioactive Compounds, Animal Behaviour, Livestock Research, Pharmaceutical Research.

Introduction

Cesar Poli’s academic career is associated with the Federal University of Rio Grande do Sul, where the ORCID record identifies him as an Associate Professor in Animal Science. His educational history includes an Agronomy degree from UFRGS, postgraduate study in Animal Science/Pastoral Science, and a Ph.D. from Massey University. These qualifications provide the documented foundation for his subsequent research and teaching activities. [1]

Research Profile

The available record describes research centered on the animal-plant interface, sheep production and management, production systems, pasture management, and integrated production and nutrition systems for ruminants. Recent publications address grazing intensity, tropical grass and legume pastures, tannins, lamb performance, animal behaviour and pasture characteristics. [2] [3]

Research Contributions

Poli’s publication record demonstrates sustained investigation of pasture-based livestock systems and nutritional factors affecting ruminant production. His documented studies include work on plant tannins, lamb growth, pasture structure, dietary preference and meat quality. A 2025 publication specifically examined plant tannin for grazing ruminant growth, while another investigated tropical grass and legume pastures grazed by lambs. [3] [4]

Publications

Cesar Poli has published research on pasture management, sheep production, ruminant nutrition, grazing behaviour, and plant bioactive compounds. His documented publications span recent studies and long-term research contributions in animal and pasture science. The research also covers lamb performance, pasture characteristics, dietary preference, and meat quality. His publication record demonstrates sustained scholarly engagement across animal science and related agricultural research areas. [1]

Research Impact

The supplied profile reports 56 documents, 719 citations and an h-index of 16 for the researcher. These bibliometric indicators provide quantitative measures of publication and citation activity, although they should be interpreted alongside disciplinary context, publication type and research collaboration. The ORCID record also documents international projects involving researchers and institutions across several countries. [1]

Award Suitability

For the International Top Pharmaceutical Awards, the Innovative Research Award profile can be considered in relation to the supplied subject classification of Biopharmaceutics and the researcher’s documented scientific record. His publications provide evidence of sustained research activity in biological production systems, nutrition, plant-derived compounds and animal science. Final award assessment should remain subject to the event’s formal evaluation criteria and independent review. [1]

Conclusion

Cesar Poli has a documented academic career at the Federal University of Rio Grande do Sul and a substantial publication record covering pasture management, sheep production, ruminant nutrition, animal behaviour and plant bioactive compounds. His ORCID record supports the chronology of his education, employment, research outputs and peer-review activity. These documented elements provide an academic basis for consideration within an innovation-focused recognition framework. [1]

References

  1. ORCID. (2026). Cesar Poli (0000-0002-8469-0779) – ORCID record. https://orcid.org/0000-0002-8469-0779
  2. Motta, J. H., Poli, C. H. E. C., Irigoyen, L. R., et al. (2026). Patterns of Plant Species Composition Under Different Grazing Intensity in Native Grasslands of Southern Brazil. Rangeland Ecology and Management. https://doi.org/10.1016/j.rama.2025.12.008
  3. Hampel, V. D. S., Poli, C. H. E. C., Tontini, J. F., et al. (2025). Physical and biochemical characteristics of tropical grass and legume pastures grazed by lambs. Grassland Science. https://doi.org/10.1111/grs.12433
  4. Poli, C. H. E. C., Tontini, J. F., Jacondino, L. R., et al. (2025). Plant tannin for grazing ruminant growth. Animal Frontiers. https://doi.org/10.1093/af/vfaf026
  5. Jacondino, L. R., Poli, C. H. E. C., Tontini, J. F., Correa, G., da Silva, I., Nigeliskii, A., Mello, R., Pereira, A., Magalhães, D., & Trindade, M., et al. (2024). Plant Bioactive Compounds of Brazilian Pampa Biome Natural Grasslands Affecting Lamb Meat Quality. Foods, 13(18), 2931. https://doi.org/10.3390/foods13182931

Mohana Vamsi Nuli | Pharmaceutical Analysis | Best Researcher Award

Published on by Top Pharmaceutical

 

Best Researcher Award

Mohana Vamsi Nuli – Penn Life Sciences

Mohana Vamsi Nuli
Name Mohana Vamsi Nuli
Affiliation Penn Life Sciences
Country United States
Scopus ID 58194986900
Documents 30
Citations 227
h-index 7
Subject Area Pharmaceutical Analysis
Event International Top Pharmaceutical Awards
ORCID 0000-0003-1900-6317

The researcher profile presented here is intended as an academic recognition article for the Best Researcher Award. The award context emphasizes documented research activity, publication quality, subject relevance, methodological contribution, and scholarly visibility. Bibliographic information and publication examples are presented as evidence for evaluating research suitability rather than as an independent assessment of scientific merit.

Abstract

Mohana Vamsi Nuli’s research profile is centered on pharmaceutical analysis and analytical method development, with published work addressing chromatographic techniques, quality-by-design methodology, and sustainable analytical practices. Available bibliographic records identify contributions to HPLC, UHPLC, and LC-MS/MS applications for pharmaceutical and biological samples. [1] [2] These areas are closely aligned with contemporary pharmaceutical research, where reliable analytical procedures are important for characterization, quantification, validation, and quality assessment.

Keywords

Pharmaceutical Analysis; HPLC; UHPLC; LC-MS/MS; Quality by Design; Analytical Chemistry; Green Analytical Chemistry; Method Validation; Pharmaceutical Quality; Chromatography; Drug Analysis; Best Researcher Award.

Introduction

Pharmaceutical analysis provides analytical foundations for drug development, formulation assessment, quality control, and biological measurement. Research in this field increasingly combines chromatographic optimization with experimental design and sustainability considerations. Nuli’s documented publications reflect this direction through studies involving UHPLC, RP-HPLC, LC-MS/MS, and quality-by-design strategies. [2] [3]

Research Profile

The supplied researcher profile records 30 documents, 227 citations, and an h-index of 7, indicating a measurable publication and citation record. The Scopus author record identifies Mohana Vamsi Nuli under Scopus ID 58194986900. His scholarly work includes analytical method development and validation, with research extending to pharmaceutical dosage forms, biological matrices, impurities, and analytical quality assessment.

Research Contributions

A notable theme is the use of design-based analytical development. His 2024 publication on molnupiravir applied Box-Behnken experimental design to UHPLC method development and impurity quantification. [2] Another study applied analytical quality by design to RP-UPLC determination of nivolumab and relatlimab, demonstrating relevance to modern pharmaceutical quality evaluation. [3]

Publications

The publication record includes recent studies in sustainable analytical chemistry and pharmaceutical analysis. Examples include research on ambrisentan-loaded solid lipid nanoparticles, green RP-HPLC determination of phenolic acids, and sustainable UHPLC analysis of antiviral combinations. [1] [4] [5] These publications illustrate a continuing interest in analytical robustness, optimization, and environmentally conscious methodologies.

Research Impact

Research impact can be considered through publication activity, citation indicators, methodological relevance, and contribution to pharmaceutical analytical practice. The supplied profile reports 227 citations and an h-index of 7, while the Scopus record reports 30 documents. These indicators provide quantitative context, although citation metrics should be interpreted alongside publication quality, research originality, methodological rigor, and field-specific standards.

Award Suitability

The documented profile is relevant to a Best Researcher Award in pharmaceutical analysis because it combines sustained publication activity with research addressing contemporary analytical challenges. The portfolio includes quality-by-design methods, chromatographic analysis, pharmaceutical impurity assessment, and green analytical approaches. [1] [3] Final award decisions should additionally consider the complete submission, verified publication record, originality, peer-reviewed impact, and the applicable evaluation criteria of the International Top Pharmaceutical Awards.

Conclusion

Mohana Vamsi Nuli presents a research profile focused on pharmaceutical analysis and analytical method development. His documented work spans chromatographic technologies, quality-by-design approaches, impurity analysis, and sustainable analytical chemistry. The combination of publication activity and reported citation indicators provides a reasonable academic basis for consideration under a Best Researcher Award framework. [2] [4]

References

  1. Singh, M., Tatapudi, H. K., Kanugo, A., Jaini, P. K., & Nuli, M. V. (2026). Application of sustainable QbD based HPLC method for quantification of carboxylic-diphenyl methane drug ambrisentan loaded in solid lipid nanoparticles. Sustainable Chemistry One World, 9, 100158.DOI: https://doi.org/10.1016/j.scowo.2025.100158
  2. Nuli, M. V., Bhikshapathi, D., Garige, A. K., Chandupatla, V., Sunkara, S. L., & Grover, P. (2024). Ultra-high-performance liquid chromatography method development for the quantification of Molnupiravir and its process-related impurities using Box-Behnken experimental design. Separation Science Plus, 7(4).DOI: https://doi.org/10.1002/sscp.202300213
  3. Nuli, M. V., Seemaladinne, R., & Tallam, A. K. (2024). Analytical quality by design (AQbD) based optimization of RP-UPLC method for determination of nivolumab and relatlimab in bulk and pharmaceutical dosage forms. Future Journal of Pharmaceutical Sciences, 10.DOI: https://doi.org/10.1186/s43094-024-00659-5
  4. Nuli, M. V., Jaini, P. K., Jami, D., Tummala, S. R., Chukka, A. K., & Tatapudi, H. K. (2025). Sustainable Quality by Design Approach Based UHPLC Technique for Triple Combination Antiviral Drugs: Appraisal of Green and White Metrics. Separation Science Plus, 8(6).DOI: https://doi.org/10.1002/sscp.70085
  5. Repudi, L., Nuli, M. V., Jaini, P. K., Seemaladinne, R., Chagarlamudi, K., & Gandla, K. (2026). Green and Robust RP-HPLC for Simultaneous Quantification of Gallic, Ferulic, and Caffeic Acids in Human Plasma via Box-Behnken Design-Based Optimization. Drug Metabolism and Bioanalysis.DOI: https://doi.org/10.2174/0118723128455332260605064308

Wenbo Hao | Enzyme | Best Research Article Award

Published on by Top Pharmaceutical

Best Research Article Award

Wenbo Hao – Henan Agricultural University, Zhengzhou, China

Wenbo Hao
Affiliation Henan Agricultural University
Country China
Scopus ID 57209716758
Documents 11
Citations 280
h-index 7
Subject Area Enzyme
Event International Top Pharmaceutical Awards
ORCID 0000-0002-2203-0986

Wenbo Hao is a researcher affiliated with Henan Agricultural University in China whose documented research record includes enzyme-based approaches for the degradation and detoxification of mycotoxins, as well as work concerning antimicrobial resistance in animal-associated bacteria. The supplied researcher records identify 11 documents, 280 citations, and an h-index of 7. The available publication information particularly identifies research involving the Lac-W laccase system and its application to multiple mycotoxins. [1] [2]

Abstract

Wenbo Hao’s documented research profile reflects a multidisciplinary research direction centered on enzymes, mycotoxin detoxification, food and feed safety, and microbiological resistance mechanisms. Records supplied from ORCID identify publications involving laccase Lac-W and mycotoxin degradation, including studies published in Toxicon: X and Toxins. The Scopus profile supplied for this article records 11 documents, 280 citations, and an h-index of 7. [1] Collectively, the documented publications provide a research basis for consideration under a research-oriented award category. [3] [4]

Keywords

Wenbo Hao; enzyme; laccase; Lac-W; mycotoxin detoxification; food safety; feed safety; biodegradation; enzymatic detoxification; antimicrobial resistance; pharmaceutical biotechnology; toxin degradation; molecular docking; agricultural biotechnology.

Introduction

Enzyme-based detoxification has attracted research interest because biological catalysts can provide alternative approaches for transforming undesirable chemical contaminants. Within the supplied publication record, Wenbo Hao is associated with studies of Lac-W, a laccase investigated for its capacity to degrade several important mycotoxins. The research includes investigations of mediator-assisted and mediator-free enzymatic systems. [3] [5]

Research Profile

The supplied Scopus profile identifies Wenbo Hao with Henan Agricultural University, Zhengzhou, China, and lists Scopus Author ID 57209716758. The same record reports 11 documents, 280 citations, and an h-index of 7. [1] The profile also indicates a collaborative publication environment involving researchers from Henan Agricultural University and other institutions.

Research Contributions

Wenbo Hao’s research contributions focus on enzyme-based mycotoxin degradation, particularly the application of Lac-W laccase for detoxifying diverse mycotoxins. His work also examines mediator-assisted enzymatic degradation and modified mycotoxins, supporting the development of biological approaches for toxin reduction. His broader research involvement also includes antimicrobial-resistance studies in animal-associated bacteria, extending his contributions across agricultural and biological research. [3]

Publications

Wenbo Hao’s documented publications include research on laccase Lac-W, mycotoxin degradation, enzymatic detoxification, and antimicrobial resistance. His publication record covers studies of fumonisins, aflatoxin B1, deoxynivalenol derivatives, and other major mycotoxins, demonstrating a continuing research interest in enzyme-mediated toxin transformation. The supplied Scopus profile records 11 documents, while the ORCID record identifies published works in Toxicon: X and Toxins. [1] [2]

Research Impact

The supplied Scopus record reports 280 citations and an h-index of 7 for Wenbo Hao, together with 11 indexed documents. [1] These metrics provide quantitative evidence of scholarly visibility within the indexed research record. The publication portfolio also demonstrates collaboration across enzyme science, food and feed safety, toxicology, veterinary science, and antimicrobial resistance. [4]

Award Suitability

The documented research record is potentially relevant to a Best Research Article Award because it contains peer-reviewed research articles addressing defined scientific problems through experimental and analytical methodologies. The publications concerning Lac-W provide a recognizable research theme involving enzymatic degradation and detoxification of mycotoxins, while the antimicrobial-resistance publication demonstrates additional collaborative research activity. [3]

Conclusion

Wenbo Hao’s documented academic profile at Henan Agricultural University includes research in enzyme science, mycotoxin detoxification, food and feed safety, and antimicrobial resistance. The supplied ORCID and Scopus records provide identifiable evidence of publications, institutional affiliation, research output, citations, and author-level metrics. The publication record therefore provides a substantive basis for academic recognition under a research article award category, subject to independent evaluation by the awarding organization.[1] [2]

References

  1. Elsevier. (n.d.). Scopus author details: Wenbo Hao, Author ID 57209716758. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57209716758
  2. ORCID. (n.d.). Wenbo Hao, ORCID iD 0000-0002-2203-0986. ORCID.https://orcid.org/0000-0002-2203-0986
  3. Xu, K., Zhang, D., Geng, C., Wang, X., Harmer, N. J., Yang, J., Zhang, J., Yang, W., & Hao, W. (2025). High-efficiency detoxification of fumonisin B1, B2 and B3 by laccase Lac-W with ABTS. Toxicon: X, 28, 100236.https://doi.org/10.1016/j.toxcx.2025.100236
  4. Jia, M., Yu, X., Xu, K., Gu, X., Harmer, N. J., Zhao, Y., Xiang, Y., Sheng, X., Li, C., Du, X.-D., Pan, J., & Hao, W. (2024). The high-efficiency degradation of multiple mycotoxins by Lac-W laccase in the presence of mediators. Toxins, 16(11), 477.https://doi.org/10.3390/toxins16110477
  5. Geng, C., Wang, X., Zhang, J., et al., & Hao, W. (2026). Detoxification of 3- and 15-acetyldeoxynivalenol and deoxynivalenol-3-glucoside by laccase Lac-W with acetosyringone. Toxicon, 282, 109214.https://doi.org/10.1016/j.toxicon.2026.109214

Bamidele Iwalokun | Immunoinformatics | Innovative Research Award

Published on by Top Pharmaceutical

Innovative Research Award

Bamidele Iwalokun — Nigerian Institute of Medical Research, Nigeria

Bamidele Iwalokun
Affiliation Nigerian Institute of Medical Research
Country Nigeria
Scopus ID 57217109793
Documents 92
Citations 1,482
h-index 23
Subject Area Immunoinformatics
Event International Top Pharmaceutical Awards
ORCID 0000-0003-4247-2797

Bamidele Iwalokun is a Nigerian biomedical researcher affiliated with the Nigerian Institute of Medical Research, where the supplied ORCID record identifies his employment as Head of Molecular Biology & Biotechnology. The same record identifies doctoral training in Biochemistry and documents a substantial body of scholarly works spanning molecular biology, infectious diseases, antimicrobial resistance, genomics and computational vaccine research. [1]

Abstract

Bamidele Iwalokun’s documented research profile encompasses molecular biology, biotechnology, infectious disease research, antimicrobial resistance, genomics and immunoinformatics. His publication record includes computational investigations of vaccine candidates and mRNA vaccine design, alongside laboratory and epidemiological studies of infectious diseases. The ORCID record supplied for this article documents multiple recent publications with established journal and DOI information. [2] [3]

Keywords

Immunoinformatics; vaccine design; mRNA vaccines; epitope-based vaccines; molecular biology; biotechnology; infectious diseases; antimicrobial resistance; genomics; computational biology; pharmaceutical research; vaccine development; biomedical innovation.

Introduction

Immunoinformatics applies computational methods to immunological data and is increasingly used to support the identification and evaluation of vaccine targets, epitopes and antigenic features. Such approaches can help organize complex biological information before experimental validation and may contribute to more systematic vaccine-development workflows. Iwalokun’s documented publications include several studies explicitly describing immunoinformatics-based approaches to vaccine design. [2]

Research Profile

His documented research profile intersects molecular biology, biotechnology, infectious disease microbiology and computational approaches to vaccine development. In particular, publications from 2024 describe immunoinformatics applications to Mokola virus, vaccinia and Mpox viruses, Epstein–Barr virus and hepatitis E virus. These works provide direct evidence for the relevance of immunoinformatics within his broader research portfolio. [2]

Research Contributions

The wider publication record includes research on multidrug-resistant organisms, resistance-associated genes, whole-genome sequencing and pathogen characterization. Examples include studies of methicillin-resistant Staphylococcus aureus, carbapenemase-producing Pseudomonas aeruginosa, multidrug-resistant Escherichia coli and molecular characteristics of other clinically important organisms. These investigations complement the computational research by addressing biological and microbiological questions relevant to infectious disease control. [5] [6]

Publications

The supplied ORCID record lists numerous scholarly works associated with Bamidele Iwalokun. Recent publications include research on infection prevention and control among healthcare workers in Nigerian COVID-19 treatment centres, the molecular landscape of methicillin-resistant Staphylococcus aureus, and computational vaccine-related studies. The record also identifies DOI information for these publications, providing persistent identifiers for scholarly verification.[4]

Research Impact

Beyond bibliometric indicators, the research record demonstrates activity across several interconnected biomedical themes. The combination of computational vaccine design, molecular characterization, antimicrobial resistance research and infectious disease studies provides a multidisciplinary foundation. This breadth may be particularly relevant to research recognition programs that consider methodological innovation and contribution to pharmaceutical or biomedical science. [1] [2]

Award Suitability

The documented research profile is substantively aligned with an Innovative Research Award because it contains peer-reviewed work applying computational and molecular approaches to contemporary vaccine-development questions. The immunoinformatics publications provide direct evidence of innovation-oriented research activity, particularly through computational vaccine design and epitope-based strategies. [4]

Conclusion

Bamidele Iwalokun’s documented scholarly profile represents a multidisciplinary research portfolio spanning molecular biology, biotechnology, infectious diseases, antimicrobial resistance and immunoinformatics. The combination of computational vaccine research and molecular infectious disease research provides a strong scholarly basis for considering the profile in the context of innovative pharmaceutical and biomedical research. The available publication evidence supports a neutral assessment of substantial research activity in areas that intersect immunoinformatics, vaccine development and translational biomedical science.[4]

References

  1. ORCID. (2026). Bamidele Iwalokun — ORCID record. ORCID.
    https://orcid.org/0000-0003-4247-2797
  2. Oladipo, E. K., Ogunniran, J. A., Akinpelu, O. S., Omole, T. O., Adeyemo, S. F., Irewolede, B. A., Iwalokun, B. A., Ajani, O. F., & Onyeaka, H. (2024). Bioinformatics designing of an mRNA vaccine for Mokola virus (MOKV) using immunoinformatics as a secure strategy for successful vaccine development. BMC Immunology.
    https://doi.org/10.1186/s12865-024-00668-2
  3. Oladipo, E. K., Oyelakin, O. D., Aiyelabegan, A. O., Olajide, E. O., Olatayo, V. O., Owolabi, K. P., Shittu, Y. B., Olugbodi, R. O., Ajala, H. A., et al. (2024). Exploring computational approaches to design mRNA vaccine against vaccinia and Mpox viruses. Immunity, Inflammation and Disease.
    https://doi.org/10.1002/iid3.1360
  4. Oladipo, E. K., Dairo, E. O., Bamigboye, C. O., Ajayi, A. F., Onile, O. S., Ariyo, O. E., Jimah, E. M., Oyawoye, O. M., Oloke, J. K., Iwalokun, B. A., et al. (2024). Harnessing immunoinformatics for precision vaccines: Designing epitope-based subunit vaccines against hepatitis E virus. BioMedInformatics, 4(3), 88.
    https://doi.org/10.3390/biomedinformatics4030088
  5. Olalekan, A., Bader, B. K., Iwalokun, B., Wolf, S., Lalremruata, A., Dike, A., Mannie-Udoh, M., Lo Presti, L., Liese, J., Guther, J., et al. (2023). High incidence of carbapenemase-producing Pseudomonas aeruginosa clinical isolates from Lagos, Nigeria. JAC-Antimicrobial Resistance.
    https://doi.org/10.1093/jacamr/dlad038

Ketan Ruparelia | Cancer Research | Research Excellence Award

Published on by Top Pharmaceutical

Research Excellence Award

Ketan Ruparelia — De Montfort University, United Kingdom

Ketan Ruparelia
Affiliation De Montfort University
Country United Kingdom
Scopus ID 6506888701
Documents 39
Citations 1,939
h-index 20
Subject Area Cancer Research
Event International Top Pharmaceutical Awards
ORCID 0000-0002-4091-2878

Ketan Ruparelia is a researcher affiliated with De Montfort University in Leicester, United Kingdom. His documented research works include studies spanning pharmaceutical and cancer-related research, including drug-delivery systems, anticancer compounds, phytochemical analysis, and medicinal chemistry. The available research record provides evidence of publications involving chemotherapy-related nanocarriers, synthetic resveratrol analogues, plant secondary metabolism, and flavone-based enzyme inhibition. These works provide a scholarly basis for considering his profile within pharmaceutical research and cancer-focused scientific activity. [1]

Abstract

Ketan Ruparelia’s documented research profile is associated with pharmaceutical and biomedical research, with particular relevance to cancer research, drug delivery, phytochemical investigation, and anticancer compound development. The available ORCID record lists five research works and identifies De Montfort University as his employment affiliation. [1]

Keywords

Ketan Ruparelia, pharmaceutical research, cancer research, drug delivery, nanomedicine, siRNA delivery, multidrug-resistant cancer, chemotherapy, mesoporous silica nanoparticles, anticancer compounds, resveratrol analogues, medicinal chemistry, phytochemical analysis, plant secondary metabolism, flavones, tyrosinase inhibitors, pharmaceutical biotechnology, International Top Pharmaceutical Awards.

Introduction

Pharmaceutical research increasingly combines medicinal chemistry, drug-delivery engineering, molecular biology, and natural-product investigation to address complex therapeutic challenges. Ruparelia’s documented works intersect several of these areas, particularly through research involving anticancer compounds and pharmaceutical delivery technologies. [1][3]

Research Profile

The ORCID record identifies Ketan Ruparelia and associates the profile with De Montfort University in Leicester, Leicestershire, United Kingdom. The employment entry specifies the position of Senior Technician in Health & Life Sciences, while the record also lists five works with Crossref-linked publication information. The supplied bibliometric profile reports 39 documents, 1,939 citations, and an h-index of 20, with Cancer Research identified as the principal subject area. [1]

Research Contributions

A central contribution documented in the available record concerns pharmaceutical nanotechnology and targeted nucleic-acid delivery. The 2025 European Journal of Pharmaceutics and Biopharmaceutics article examines electrosprayed core-shell polyethyleneimine and phospholipid-coated mesoporous silica nanoparticles for co-delivery of KAZ3 and MDR-1 siRNA. [1]

Publications

Ketan Ruparelia’s publications span pharmaceutical nanotechnology, cancer research, medicinal chemistry, and phytochemical analysis. His 2025 article on electrosprayed core-shell nanoparticles investigated KAZ3 and MDR-1 siRNA co-delivery for chemotherapy in multidrug-resistant colon cancer. [1] His other works examine synthetic resveratrol analogues, indanone-based chalcone analogues, plant secondary metabolism, and flavone tyrosinase inhibition. [2]

Research Impact

The reported bibliometric profile indicates 39 documents, 1,939 citations, and an h-index of 20. These figures provide quantitative indicators of scholarly visibility within the supplied profile, while the underlying publication record demonstrates activity across pharmaceutical delivery, cancer research, medicinal chemistry, and phytochemical investigation. In particular, nanoparticle-mediated siRNA delivery connects pharmaceutical formulation with cancer biology, whereas resveratrol analogue research links synthetic chemistry with anticancer investigation. [1][3]

Award Suitability

The documented research profile is relevant to a Research Excellence Award within a pharmaceutical research context because it encompasses multiple areas directly connected with drug development and cancer-oriented pharmaceutical science. The evidence includes peer-reviewed journal articles, DOI-indexed works, and research involving drug-delivery systems and anticancer compounds. [1][3]

Conclusion

Ketan Ruparelia’s documented research profile reflects interdisciplinary activity relevant to pharmaceutical and cancer research. His recorded works encompass nanocarrier-based siRNA delivery, anticancer resveratrol analogues, synthetic chemistry, phytochemical analysis, and enzyme-inhibitor research. The combination of these research areas provides a substantive scholarly basis for recognition under a pharmaceutical research excellence category.[1][3]

References

  1. Sayed, E., Ruparelia, K., Zafar, S., Faheem, A., Fatouros, D., Arshad, M. S., Singh, N., & Ahmad, Z. (2025). Novel electrosprayed core-shell polyethyleneimine and phospholipid coated MSNs for Co-delivery of KAZ3 and MDR-1 siRNA for efficient chemotherapy in multidrug-resistant colon cancer. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2025.114838
  2. Pal, P., Ruparelia, K. C., Arroo, R. R. J., & Brucoli, F. C. (2025). A Green Chemistry Approach for the Synthesis of Indanones as Fixed Ring Chalcone Analogues. Preprints. https://www.preprints.org/manuscript/202504.1089
  3. Ruparelia, K. C., Zeka, K., Beresford, K. J. M., Wilsher, N. E., Potter, G. A., Androutsopoulos, V. P., Brucoli, F., & Arroo, R. R. J. (2024). CYP1-Activation and Anticancer Properties of Synthetic Methoxylated Resveratrol Analogues. Molecules, 29(2). https://doi.org/10.3390/molecules29020423
  4. Arroo, R. R. J., Bhambra, A. S., Hano, C., Renda, G., Ruparelia, K. C., & Wang, M. F. (2021). Analysis of plant secondary metabolism using stable isotope-labelled precursors. Phytochemical Analysis. https://doi.org/10.1002/pca.2955
  5. Arroo, R. R. J., Sari, S., Barut, B., Özel, A., Ruparelia, K. C., & Şöhretoğlu, D. (2020). Flavones as tyrosinase inhibitors: kinetic studies in vitro and in silico. Phytochemical Analysis. https://doi.org/10.1002/pca.2897

Ruth Etiosa Olusola | Medicinal Chemistry | Best Researcher Award

Published on by Top Pharmaceutical

Best Researcher Award

Ruth Etiosa Olusola 
Caleb University, Nigeria

Ruth Etiosa Olusola
Affiliation Caleb University
Country Nigeria
Scopus ID 59166859900
Documents 9
Citations 251
h-index 4
Subject Area Medicinal Chemistry
Event International Top Pharmaceutical Awards
Google Scholar 5PU6WugAAAAJ

Ruth Etiosa Olusola (Nee Ogbemudia) is a researcher affiliated with Caleb University, Imota, Nigeria, whose documented scholarly interests include organic chemistry, natural product chemistry, organic synthesis, plant bio-assay and heavy-metal analysis. Her research record includes studies of plant-derived constituents, phytochemical profiling, nutritional composition, antimicrobial activity and analytical approaches relevant to pharmaceutical and natural-product research. Her Google Scholar profile records 251 citations and an h-index of 4, providing a measurable basis for considering her research profile within the scope of the Best Researcher Award. [1]

Abstract

Ruth Etiosa Olusola is a Nigerian researcher whose academic profile combines organic chemistry and natural-product research with analytical and bioassay-oriented investigations. The available scholarly record identifies Caleb University, Imota, as her institutional affiliation and lists organic chemistry, natural product chemistry, organic synthesis, plant bio-assay and heavy-metal analysis among her research areas. [1] Her publication record includes work on soybean composition, phytochemical characterization of Aspilia africana, chitosan-based heavy-metal adsorption and investigations of Spilanthes filicaulis. [2] These studies collectively demonstrate an interdisciplinary research profile connecting chemistry, natural products, analytical science and pharmaceutical research.

Keywords

Ruth Etiosa Olusola, Best Researcher Award, Medicinal Chemistry, Organic Chemistry, Natural Product Chemistry, Organic Synthesis, Plant Bio-assay, Phytochemical Analysis, GC-MS, Antimicrobial Research, Pharmaceutical Research, Natural Products, Heavy Metal Analysis, Chitosan Adsorption, Spilanthes filicaulis, Aspilia africana, International Top Pharmaceutical Awards.

Introduction

Natural-product and medicinal-chemistry research provides an important scientific pathway for investigating biologically active compounds and chemically characterizing materials derived from plants and other natural sources. Olusola’s documented work fits within this broad research landscape through studies involving phytochemical screening, GC-MS analysis, antimicrobial investigation and computational assessment of plant-derived compounds. [3] Her research also extends into analytical chemistry through mineral and proximate composition studies and investigations of heavy-metal removal using modified chitosan materials. [4]

Research Profile

The research profile documented for Olusola identifies Organic Chemistry and Natural Product Chemistry as central areas, alongside Organic Synthesis, Plant Bio-assay and Heavy Metal Analysis. [1] Her publications show practical application of these areas through chemical extraction, phytochemical screening, chromatographic analysis and biological evaluation. In particular, her work on Aspilia africana used phytochemical studies and GC-MS analysis to characterize compounds present in chloroform leaf extracts. [2]

Research Contributions

A significant contribution of the documented research is the investigation of plant materials as sources of phytochemicals and potentially useful bioactive compounds. Research involving Spilanthes filicaulis has examined its ethnopharmacological importance and summarized available evidence concerning its chemical and pharmacological characteristics. [5] A subsequent 2026 study involving Olusola investigated antimicrobial effects, phytochemical profiling and in-silico analysis of compounds from the plant, thereby connecting experimental biological testing with computational drug-development approaches.

Publications

The available profile lists nine documents published between 2016 and 2026, covering plant chemistry, nutritional composition, adsorption materials, and pharmacological research. The publications demonstrate a multidisciplinary research profile spanning natural products, analytical chemistry, and pharmaceutical-related investigations. [1] Several of the listed studies have identifiable DOI records, providing persistent links for independent access to the corresponding scholarly publications.

Research Impact

The available Google Scholar record reports 251 citations and an h-index of 4, indicating that the documented publications have received measurable scholarly attention. [1] The profile also records an i10-index of 2. Her highly cited work on soybean composition demonstrates substantial visibility within the listed record, while her more recent work on Spilanthes filicaulis extends the research portfolio toward antimicrobial activity, phytochemical profiling and computational analysis[3]

Award Suitability

The documented combination of publication activity, citation impact and interdisciplinary chemistry research provides a reasonable academic basis for consideration for a Best Researcher Award. Her work connects organic and natural-product chemistry with phytochemical characterization, plant bio-assay, analytical investigation and research relevant to pharmaceutical discovery. The 2026 study integrating antimicrobial assays, phytochemical profiling and in-silico analysis further demonstrates a contemporary research direction that links natural products with potential drug-development investigations. [3]

Conclusion

Ruth Etiosa Olusola represents a chemistry-focused research profile with documented activity in organic chemistry, natural products, phytochemical analysis, plant bio-assay and analytical research. Her publication record includes studies of medicinal plants, nutritional composition, antimicrobial properties and adsorption materials. The available citation indicators, together with her continuing publication activity, provide relevant evidence for academic recognition under a Best Researcher Award framework. [1]

References

    1. Google Scholar. (n.d.). Ruth Etiosa Olusola (Nee Ogbemudia), author profile. Google Scholar. Citation and bibliographic information accessed from the supplied researcher profile.https://scholar.google.com/citations?user=5PU6WugAAAAJ&hl=en
    2. Ogbemudia, R. E., Adeyemo, J. A., & Nwadozie, B. C. (2018). Phytochemical Studies and GC-MS Analysis of Chloroform Extract of the Leaves of Aspilia africana. Asian Journal of Physical and Chemical Sciences. https://doi.org/10.9734/AJOPACS/2017/38663
    3. Ojo, O., Olusola, R. E., & Ojo, O. O. (2024). Spilanthes filicaulis (Schumach. & Thonn.) C. D. Adams: An insights into ethnopharmacologically important but scientifically understudied species. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2024.05.010
    4. Olohigbe, A. B., Ogbemudia, R. E., & Okiei, W. (2018). Highly Deacetylated Chitosan as Low-cost Adsorbent Material for Removal of Heavy Metals from Water. Asian Journal of Physical and Chemical Sciences. https://doi.org/10.9734/AJOPACS/2018/38599
    5. Ogbemudia, R. E., Nnadozie, B. C., & Anuge, B. (2018). Mineral and Proximate Composition of Soya Bean. Asian Journal of Physical and Chemical Sciences. https://doi.org/10.9734/AJOPACS/2017/38530

Onwu Daniel Ocha | Drug Discovery | Best Researcher Award

Published on by Top Pharmaceutical

Best Researcher Award

Onwu, Daniel Ocha
Affiliation University of Cross River State
Country Nigeria
Google Scholar ID n6jcvPsAAAAJ
Documents 9
Citations 2
h-index 1
Subject Area Drug Discovery
Event International Top Pharmaceutical Awards

Onwu Daniel Ocha – University of Cross River State

Onwu Daniel Ocha is a researcher affiliated with the University of Cross River State (UNICROSS), Calabar, Nigeria. His reported scholarly work is associated with computational biology, bioinformatics, drug discovery, network pharmacology, phytochemical investigation, and computational modelling. The supplied Google Scholar record reports nine documents, two citations, and an h-index of one. The profile also identifies computational biology and bioinformatics among the research areas associated with his scholarly activity.

Abstract

Onwu Daniel Ocha’s research profile reflects interdisciplinary activity connecting computational biology and bioinformatics with pharmaceutical and biomedical investigation. His available publication record includes research on phytochemicals, network pharmacology, computational modelling, biological targets, infectious diseases, and therapeutic investigation. These subjects are relevant to modern drug discovery because computational approaches can support the identification of candidate compounds, molecular targets, pathways, and potential mechanisms of action. His research record therefore demonstrates an emerging connection between computational science and pharmaceutical research. [1]

Keywords

Drug Discovery; Computational Biology; Bioinformatics; Network Pharmacology; Computational Modelling; Molecular Docking; Phytochemicals; Drug Target Identification; Systems Biology; Therapeutic Targeting; Pharmaceutical Research; In-silico Research; Biomedical Informatics.

Introduction

Computational biology and bioinformatics have become important components of modern pharmaceutical research. Computational approaches can be used to examine molecular interactions, biological pathways, disease-associated targets, and candidate therapeutic compounds before or alongside laboratory validation. Network pharmacology is particularly useful for studying complex relationships between compounds, proteins, pathways, and disease mechanisms. These approaches can contribute to the prioritization of potential therapeutic candidates and provide hypotheses for subsequent experimental research [1].

Research Profile

The supplied academic profile identifies Onwu Daniel Ocha with the University of Cross River State (UNICROSS), Calabar, Nigeria. His Google Scholar record reports nine documents, two citations, and an h-index of one. The research areas represented in the supplied profile include computational biology and bioinformatics, while the award profile specifically identifies Drug Discovery as the subject area. This combination places his research at the intersection of computational science and pharmaceutical investigation.[3]

Research Contributions

A notable contribution in the supplied publication record is the study titled In-Silico and Network Pharmacology Analysis of Mimosa invisa Phytochemicals against Testicular Inflammation. The work examines phytochemical compounds using computational approaches to investigate their potential relationships with inflammation-associated biological targets. This research direction is relevant to drug discovery because phytochemicals may provide candidate structures for further pharmacological investigation [3].

Publications

The available publication record demonstrates continuing scholarly activity in computational and biomedical research. Listed publications include studies on Mimosa invisa phytochemicals, biosynthesized silver nanoparticles, Terminalia catappa extracts, Allium cepa bioactive compounds, drug-resistant tuberculosis, Tefairia occidentalis phytocompounds, and computational analysis of antiviral targets. The diversity of these topics indicates an interdisciplinary research approach involving computational methods and biological investigation.[3].

Research Impact

The supplied Google Scholar profile reports two citations and an h-index of one. These bibliometric indicators represent the citation activity recorded by the profile at the time of the supplied document and may change as additional publications are indexed and cited. Therefore, citation indicators should be considered together with publication quality, research relevance, collaboration, and scientific contribution when assessing an emerging researcher.[4].

Award Suitability

The award assessment should nevertheless remain evidence-based and should consider the complete research portfolio, verified publication records, originality, methodological quality, scholarly contribution, collaboration, and the official eligibility criteria established by the award organizers. The available profile demonstrates an emerging publication record rather than providing sufficient evidence for unsupported claims of exceptional impact. This distinction maintains a neutral academic approach to recognition[4].

Conclusion

Onwu Daniel Ocha’s documented research profile demonstrates interdisciplinary activity involving computational biology, bioinformatics, drug discovery, network pharmacology, phytochemicals, and systems biology. The supplied record identifies nine documents, two citations, and an h-index of one, while the listed publications demonstrate research activity across several biomedical and pharmaceutical themes. [1].

References

  1. Onwu, D. O., Uraku, O. H., Agbi, M. T., & Uraku, A. J. (2026). In-silico and network pharmacology analysis of Mimosa invisa phytochemicals against testicular inflammation. In Silico Research in Biomedicine, 2, 100274.
    https://doi.org/10.1016/j.insi.2026.100274
  2. Onwu, D., Edun, S., Asuquo, U., & Bajepade, T. I. (2025). Antidiabetic potential of biosynthesized silver nanoparticles with fresh guava leaf. Covenant Journal of Physical and Life Sciences, 13(2), 1–6.
    https://journals.covenantuniversity.edu.ng/index.php/cjpls/article/view/4978
  3. Onwu, D. O., Kayode, D., Oluwatosin, C. E., Chimaobi, N. G., Johnson, O., et al. (2026). Assessing the effects of aqueous extract of Terminalia catappa on immunoglobulins levels in cyclophosphamide induced immunosuppressant Wistar rats. Next Research, 101441.
    https://doi.org/10.1016/j.nexres.2026.101441
  4. Onwu, D. O., Singh, A., Bajpai, Y., Akinlamilo, A. S., Habiganuchi, A., & Ibikunle, F. O. (2025). Host–pathogen interaction mapping in drug-resistant tuberculosis: A systems biology framework for dual therapeutic targeting. Research Square.
    https://doi.org/10.21203/rs.3.rs-7855974/v1
  5. Ahmad, A., Nnenna, A. O., Mamman, S., Nwokoro, C., Bello, A. M., Nseabasi, M. A., Abdulwakiil, M., Okpe, J., Onwu, D. O., Agbi, M., & Idoko, A. (2025). In-silico network pharmacology and computational modelling of bioactive compounds from Allium cepa targeting downstream protein effectors in diabetes. Research Square.
    https://doi.org/10.21203/rs.3.rs-8181479/v1